HomepageAbout us

About us

Aedifica is a listed company that specialises in investments in European healthcare real estate, in particular housing for seniors with care needs. For fifteen years, we have followed a successful strategy: a high-quality diverse portfolio that generates recurring and indexed rental income, combined with industry leading long-term partners and a collaborative and experienced team focused on strong returns, offering our shareholders a reliable and sustainable real estate investment with an attractive yield. At Aedifica, social sustainability is a fundamental driving force: we empower healthcare providers and innovators to care for more people than ever before. We don’t just invest in properties, we invest in society.

Our strategy

Growth potential

Aedifica is investing in a real estate sector with strong growth potential. Europe’s population is increasingly ageing and living longer: by 2060, more than 10% of the population will be aged over 80. Over the next 40 years, this demographic trend will drive the demand for healthcare real estate. In addition, care operators (specifically in the consolidating private segment) are developing their business, while governments only have limited resources to meet the growing demand and, hence, focus more often on financing care and care dependency rather than on providing care as a public operator. As a result, both private operators and public authorities are counting on private investors to provide and finance real estate infrastructure that responds to the care and housing needs of the ageing population.

  • >25 million people over 80 years in the EU
  • 130% expected growth of EU population over 80 years from 2018-2050

Expertise

Aedifica responds in an agile way to the increasing market demand and the specific real estate needs of care operators because of the expertise and knowledge we have developed over the past 15 years. We align with superior care operators and invest in their long-term growth alongside our own. As a result of our long-term partnerships with operators, we are aware of their specific needs, enabling us to invest in buildings that integrate innovative care concepts and technologies, either by developing, redeveloping, buying and/or renovating these properties. Aedifica’s expertise makes us the ideal partner for investments in healthcare real estate and sets us apart from other investors in the sector.

Diversification

Aedifica expands and optimises its real estate portfolio by constructing brand-new care facilities and by acquiring, renovating and/or expanding existing buildings. In order to limit risks and avoid over-reliance on a particular social security system, we are building a balanced portfolio by diversifying our investments from a geographical point of view as well as in terms of tenants and asset type.

  • 450+ properties
  • 32,000 seniors living and ageing with dignity

6 European countries

Aedifica has a proven track record of entering new markets and rapidly creating a platform for future growth. We made ourselves at home in 6 countries: Belgium, Finland, Germany, the Netherlands, Sweden and the United Kingdom. Given this diversified geographical spread, Aedifica does not depend on a single social security system and can further diversify its tenant base. In the future, we intend to continue exploring new European markets.

>90 operator groups

We rent out our care facilities to more than 90 groups of professional and specialist care operators (profit and not-for-profit operators, as well as public operators) on the basis of long-term contracts that generate high rental yields. Each care group that operates Aedifica property generates less than 15% of our total rental income, which therefore benefits from a diverse income stream.

Asset types

We also diversify our investments by asset type. Our primary focus is to meet the growing demand resulting from demographic developments by investing in different types of housing for seniors: elderly care homes for seniors with high care needs, seniors housing for persons who prefer to live independently with on-demand care options, and facilities that combine both types of housing (some facilities combine elderly care with other care functions such as day-care centres, medical centres, etc.). In addition, we invest in real estate for disabled persons and other people in need of specialist residential care or specialist day-care. In the Northern Europe, we also invest in children day-care centres (‘preschool’), whether as stand-alone centres or in combination with other care or school facilities, driven by the urbanisation trend in Finland and Sweden leading to a specific demand for this type of centres.

  • Geographical breakdown

    in fair value (%)

  • Breakdown of contractual rent

    by operator group (%)

  • Breakdown by facility type

    in fair value (%)
  • -10% our ambition to reduce our ecological footprint by 2025

Sustainability

Sustainability is deeply embedded in Aedifica’s DNA, because we believe growing our company goes hand in hand with helping our people and the communities around us thrive, while safeguarding our planet. We are committed to environmentally and socially responsible investment and development in collaboration with our operating partners, all the way from start to finish. Assuming our responsibilities towards society, we developed an ambitious CSR action plan, which we intend to carry out by 2025. For more information about our CSR commitments and our action plan, have a look at our sustainability page.

SUSTAINABILITY

Our values

  • Agility icon Care
    We care about the people in our community and take meaningful action to have a positive impact on their lives. We invest in innovative housing solutions for our residents, we are a loyal long-term partner for our tenants, and we create an inclusive and empathic workplace for our team.
  • Care icon Agility
    We are a dynamic European company that easily adapts to the specificities of the market of each of the countries in which we invest. Being agile permits us to use our international expertise, while taking into account the local situation, so we can respond to the needs of our tenants in a flexible way.
  • Transparency
    Transparent, ethical and sound management are of the greatest importance to us. That is why we pursue a business culture that is characterised by honesty and integrity, a sense of responsibility, strict ethics and compliance with the corporate governance standards.
  • Leadership icon Leadership
    As a pure-play healthcare real estate investor with dedicated local teams in all of our markets across Europe, we are a pioneer in the consolidation of the European healthcare real estate market. By investing in quality and innovation and by sharing our broad experience with our tenants, we make sure we stay ahead of the pack.

Our key figures

  • 454 assets
  • €3.4 bn fair value portfolio
  • 28% compound annual growth rate
  • €163 m YTD rental income
  • 20 years WAULT (weighted average lease term)
  • 100% occupation rate
  • 50% debt-to-assets ratio
  • 44 employees
  • €4.60 total gross dividend 2019/2020

Our history

  • 2005
    • Formation of Aedifica
    • Portfolio includes apartments and hotels
  • 2006
    • Listing on Euronext Brussels
    • First investments in healthcare real estate
  • 2010

    1st public capital increase of €67 million
  • 2012

    2nd public capital increase of €100 million
  • 2013

    First investments in Germany
  • 2015

    3rd public capital increase of €153 million
  • 2016

    First investments in the Netherlands
  • 2017
    • 4th public capital increase of €219 million
    • Aedifica is the most active private investor in Dutch healthcare real estate
    • Agreement for the construction of 17 care campuses in Germany (investment of €250 million)
  • 2018
    • Aedifica is again the most active private investor in Dutch healthcare real estate
    • ‘Investor des Jahres 2018’ award in Germany
  • 2019
    • First investment in the UK (£450 million)
    • 5th public capital increase of €418 million
    • Divestment of apartments and hotel portfolio
    • Secondary listing on Euronext Amsterdam
  • 2020
    • First investment in Finland and Sweden (acquisition of Hoivatilat)
    • 6th capital increase of €207 million
    • Entry in the BEL 20, the leading share index of Euronext Brussels

Get directions

Do you want to pay us a visit at the office? The coffee is ready, you are more than welcome.

We have made sure that you can easily get to our head office in Brussels by public transport: you can reach us by train, metro, bus and bicycle.

If you come by train, you can get off at the station of Brussels-Luxemburg or Brussels-Central. From there you can easily continue on foot to rue Belliard 40. If you come by international train, you get off at Brussels-South station and take metro line 2 or 6 to Trône/Troon or Arts-Loi/Kunst-Wet.

If you come by metro, you can take line 1 or 5 to Arts-Loi/Kunst-Wet or Maelbeek/Maalbeek, or you can take line 2 or 6 to Trône/Troon or Arts-Loi/Kunst-Wet.

If you come by bus, you can take line 21, 27 and 64 to Trêves/Trier, or line 27, 34, 38, 64, 80 and 95 to Science/Wetenschap.

If you take a villo! sharing bike, you can easily park your bike in the Charlemagne/Karel De Grote bike station right in front of our office.

Of course, you can also reach us by car, but we encourage you to consider the environment and use public transport or other eco-friendly transportation options.

Disclaimer

The following restricted pages of the website of Aedifica NV (the “Company”) contain information in respect of a contemplated transaction by the Company. Nothing on this website (or any website to which this website has been hypertext linked) constitutes an invitation or offer to acquire any securities of the Company or any of its subsidiaries.

THE INFORMATION IN THE FOLLOWING PAGES IS NOT INTENDED FOR, AND IS NOT TO BE MADE AVAILABLE TO, ANY PERSON THAT IS RESIDING, DOMICILED OR PHYSICALLY PRESENT IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SWITZERLAND OR SOUTH AFRICA.

The following information may only be consulted by investors that may have access to such information as allowed under the applicable regulations. These documents are made available for information purposes only. The reproduction of these electronic versions (i) on another website or at any other virtual or physical location, or (ii) in a printed form or on any other carrier for the purpose of distributing these documents, in any manner whatsoever, is strictly forbidden.

The information is made available for information purposes only and is not in any manner intended to constitute an offer or invitation to proceed to an acquisition of, or subscription to, any of the Company’s securities in, or towards residents, inhabitants, or citizens of, the United States, Canada, Australia, Japan, Switzerland, South Africa or any other jurisdiction where such offering or solicitation is not permitted without registration, exemption from registration or qualification under the applicable legislation of the relevant jurisdiction, or does not meet the required conditions under the applicable legislation of the relevant jurisdiction.

The information contained on this website and in the following information does not constitute an offer of securities for sale in the United States, Australia, Canada, Japan, South Africa, Switzerland or in any other jurisdiction in which such offers or sales are unlawful. The Company’s securities have not been, nor will be, registered under the United States Securities Act of 1933, as amended (the “US Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction in the United States. There will be no public offer of securities in the United States.

The Company’s securities may not be offered or sold in the United States without prior registration under the US Securities Act, or unless the transaction is exempt from, or not subject to, the registration requirements of the US Securities Act and any applicable state securities laws.

No information contained in the following information, or any copy thereof, may, directly or indirectly, be taken or sent to, or distributed in, the United States, Canada, Australia, Japan, Switzerland, South Africa or any other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. Non-compliance with these provisions may constitute a breach of the applicable legislation in the United States, Canada, Australia, Japan, Switzerland, South Africa or any other applicable jurisdiction. The dissemination of information contained in the following information or on the Company’s website may be subject to legal restrictions and persons who become aware of and/or receive such information must inform themselves about any applicable legal restrictions and must comply with such restrictions.

In the European Economic Area, the following information is only addressed to and is only directed at qualified investors in that Member State within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, and any implementing measure in each relevant Member State of the EEA (the “Prospectus Regulation”) (“Qualified Investors”).

In general, any person who would like to receive access to the following information must verify in advance that such access does not constitute a breach of any applicable law or regulations. The Company cannot be held liable should these restrictions be breached by any person. While the Company has taken reasonable care to ensure that the information on this website (other than information accessed by hyperlink) is accurate at the time of last revision of the website, the Company accepts no liability for the accuracy or completeness or use of, nor any liability to update, the information contained on this website. The information on the Company’s website or contained in the following information should not be construed to constitute any form of advice or recommendation, including but not limited to investment, tax, legal or other advice, and should not be relied upon as the basis for any decision or action. In particular, actual results and developments may differ in a material manner from any forecast, forward-looking statement, opinion or expectation expressed in the following information or on the Company’s website.

By selecting “yes, I confirm and certify”, you will be granted access to the following electronic information, provided that:

(a) you confirm and certify that you have read, understand and will comply with, the warnings and restrictions stated above; and

(b) you confirm and certify that:

(i) you are not domiciled or a resident of, and are not accessing this information from, the United States, Australia, Canada, Japan or South Africa, subject to (ii) below;

(ii) you are not a US person (as defined in Regulation S under the US Securities Act unless you are a qualified institutional buyer (“QIB”), as defined in and in reliance on Rule 144A of the US Securities Act);

(iii) you are a Qualified Investor within the meaning of Prospectus Regulation 2017/1129;

(iv) you do not live, reside or are located in any other jurisdiction where the distribution of this information is not legally permitted;

(v) you are a person who may and is permitted to receive this information; and

(vi) in all circumstances, you agree not to transmit or otherwise send any information from this website to any person who may not receive this information or would otherwise breach applicable laws and regulations or would require registration or licensing.